Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

Read More

Overview

Feature Articles

Latest Multiple Myeloma News and Research

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

New review analyzes appropriateness of off-pathway cancer care

New review analyzes appropriateness of off-pathway cancer care

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

New tool may predict best treatment for multiple myeloma

New tool may predict best treatment for multiple myeloma

Combination therapy does not show superior efficacy in newly diagnosed myeloma

Combination therapy does not show superior efficacy in newly diagnosed myeloma

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

A promising strategy to overcome drug resistance developed by blood cancer cells

A promising strategy to overcome drug resistance developed by blood cancer cells

Gero uses AI platform to identify potential anti-COVID-19 drugs

Gero uses AI platform to identify potential anti-COVID-19 drugs

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Research reveals novel way to treat cancers using CAR T cell therapy

Research reveals novel way to treat cancers using CAR T cell therapy

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

SU2C announces international team for fighting gastric cancer

SU2C announces international team for fighting gastric cancer

Daratumumab proves effective in patients with relapsed AL amyloidosis

Daratumumab proves effective in patients with relapsed AL amyloidosis